Endocrine Tumours and Neoplasia

It is estimated that over 12,000 Americans are diagnosed with an endocrine tumor every year. Over 1,500 people in the United States are diagnosed with Merkel cell skin cancer each year. Most of the people diagnosed with the disease are over age 50, and 90% of cases occur in white people. The 5-year survival rate of people with Merkel cell cancer is about 60%. MEN1 (Multiple endocrine neoplasia type 1) is a hereditary condition associated with tumors of the endocrine glands. MEN1 was originally known as Wermer syndrome. It is estimated that about 1 in 30,000 people has MEN1. According to studies, about 10% of people with MEN1 do not have a family history of the condition; they have a de novo (new) mutation in the MEN1 gene. Follow Endocrinology Conferences and Diabetes Conferences for more updates.

    Related Conference of Endocrine Tumours and Neoplasia

    September 20-21, 2019

    15th World Congress on Endocrinology & Diabetes

    | Prague, Czech Republic
    September 20-21, 2019 |

    Euro Diabetes Congress & Expo

    Prague, Czech Republic
    October 23-24, 2019

    Annual Summit on Metabolomics

    Amsterdam, Netherlands
    November 11-12, 2019

    Annual Congress on Diabetes, Metabolism and Obesity

    Sydney, Australia
    November 25-26, 2019

    Annual Congress on Endocrinology, Diabetes and Healthcare

    Bangkok,Thailand
    December 02-03, 2019

    14th European Diabetes and Endocrinology Congress

    | Barcelona, Spain
    Diabetes Congress 2019 | December 04-05, 2019 |

    3rd Annual Congress on Diabetes and Its Complications

    Tokyo, Japan
    December 12-13, 2019

    Annual Congress on Diabetes and Endocrinology

    | Dubai, UAE
    January 29-30, 2020

    Global Summit On Diabetes & Endocrinology

    | Holiday Inn Atrium | Singapore
    March 25-26, 2020

    29th World Diabetes & Heart Congress

    | Radisson Narita | Tokyo, Japan

    Endocrine Tumours and Neoplasia Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in